Synapse - Andrew Plodkowski

Results (39)

Outcomes of combination platinum-doublet chemotherapy and anti-PD(L)-1 blockade in KRAS(G12C) mutant non-small cell lung cancer

Journal Article

Elkrief, A.; Riccuiti, B.; Alessi, J. V.; Fei, T.; Kalvin, H. L.; Egger, J. V.; Rizvi, H.; Thummalapalli, R.; Lamberti, G.; Plodkowski, A.; more...
The Oncologist (2023)

Fulltext@MSK | Save

The GENIE BPC NSCLC cohort: A real-world repository integrating standardized clinical and genomic data for 1,846 patients with non-small cell lung cancer

Journal Article

Choudhury, N. J.; Lavery, J. A.; Brown, S.; de Bruijn, I.; Jee, J.; Tran, T. N.; Rizvi, H.; Arbour, K. C.; Whiting, K.; Shen, R.; more...
Clinical Cancer Research (2023)

Fulltext@MSK | Save

Targeting NFE2L2/KEAP1 mutations in advanced NSCLC with the TORC1/2 inhibitor TAK-228

Journal Article

Paik, P. K.; Fan, P. D.; Qeriqi, B.; Namakydoust, A.; Daly, B.; Ahn, L.; Kim, R.; Plodkowski, A.; Ni, A.; Chang, J.; more...
Journal of Thoracic Oncology (2023)

Fulltext@MSK | Save

Bioinformatically expanded next-generation sequencing analysis optimizes identification of therapeutically relevant MET copy number alterations in >50,000 tumors

Journal Article

Solomon, J. P.; Yang, S. R.; Choudhury, N. J.; Ptashkin, R. N.; Eslamdoost, N.; Falcon, C. J.; Martin, A.; Plodkowski, A.; Wilhelm, C.; Shen, R.; more...
Clinical Cancer Research (2022)

Fulltext@MSK | Save

Immune biomarkers and response to checkpoint inhibition of BRAF(V600) and BRAF non-V600 altered lung cancers

Journal Article

Murciano-Goroff, Y. R.; Pak, T.; Mondaca, S.; Flynn, J. R.; Montecalvo, J.; Rekhtman, N.; Halpenny, D.; Plodkowski, A. J.; Wu, S. L.; Kris, M. G.; more...
British Journal of Cancer (2022)

Fulltext@MSK | Save

The effects of neoadjuvant chemotherapy and intervalde bulking surgery on body composition in patients with ovarian cancer

Journal Article

Vitarello, J.; Goncalves, M. D.; Zhou, Q. C.; Iasonos, A.; Halpenny, D. F.; Plodkowski, A.; Schwitzer, E.; Mueller, J. J.; Zivanovic, O.; Jones, L. W.; more...
JCSM Clinical Reports (2021)

Fulltext@MSK | Save

Response to immune checkpoint inhibition as monotherapy or in combination with chemotherapy in metastatic ROS1-rearranged lung cancers

Journal Article

Choudhury, N. J.; Schneider, J. L.; Patil, T.; Zhu, V. W.; Goldman, D. A.; Yang, S. R.; Falcon, C. J.; Do, A.; Nie, Y.; Plodkowski, A. J.; more...
JTO Clinical and Research Reports (2021)

Fulltext@MSK | Save

Response to immune checkpoint inhibition as monotherapy or in combination with chemotherapy in metastatic ROS1-rearranged lung cancers

Meeting Abstract

Choudhury, N. J.; Schneider, J. L.; Patil, T.; Zhu, V. W.; Goldman, D. A.; Yang, S. R.; Falcon, C.; Do, A.; Nie, Y.; Plodkowski, A. J.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

Intra- and inter-reader agreement of iRECIST and RECIST 1.1 criteria for the assessment of tumor response in patients receiving checkpoint inhibitor immunotherapy for lung cancer